2200 Powell Street
Suite 310
Emeryville, CA 94608
United States
510 204 7200
https://www.xoma.com
Sector(es): Healthcare
Industria: Biotechnology
Empleados a tiempo completo: 13
Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
---|---|---|---|---|
Mr. Owen P. Hughes Jr. | CEO & Director | 193.75k | N/D | 1975 |
Mr. Thomas M. Burns | Senior VP of Finance & CFO | 759.24k | N/D | 1974 |
Mr. Brad Sitko | Chief Investment Officer | 867.08k | N/D | 1981 |
XOMA Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with various assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
La calificación ISS Governance QuickScore de XOMA Corporation a partir del 1 de marzo de 2024 es 4. Las puntuaciones principales son Auditoría: 7; Junta: 3; Derechos del accionista: 2; Compensación: 7.